Medication info

Rinatine Mpa Tablet 25/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mgLinagliptin Micronized›5mg
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202502794 · Approved 2025.10.29

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed in patients who tolerate empagliflozin 10 mg/linagliptin 5 mg, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should receive the same doses they were taking previously. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an eGFR of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Elderly patients No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medicine is used to assist dietary and exercise therapy in controlling blood sugar in patients with type 2 diabetes. The ingredients empagliflozin and linagliptin work together to effectively help manage blood sugar levels. Therefore, taking this medicine can improve blood sugar management and contribute to the treatment of diabetes.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed in patients who tolerate empagliflozin 10 mg/linagliptin 5 mg, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should receive the same doses they were taking previously. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an eGFR of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Elderly patients No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medicine consists of two ingredients, empagliflozin and linagliptin, and is primarily used for the treatment of type 2 diabetes. First, it should not be used by individuals who are allergic to empagliflozin, linagliptin, or any other ingredients in this medicine. It is also not to be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. Second, patients with impaired kidney function should regularly undergo kidney function tests prior to using this medicine, and exercise caution if taking other medications that may affect kidney function. Caution is also necessary for patients with heart failure, and if symptoms of acute pancreatitis occur, the medication should be stopped immediately. Additionally, if symptoms resembling blistering disorders like bullous pemphigoid appear on the skin, consult a doctor immediately. Third, when taking this medicine, side effects such as urinary tract infections, genital infections, hypoglycemia, dehydration, and low blood pressure may occur, so be vigilant for symptoms. Particularly, if taking sulfonylureas or insulin together, the risk of hypoglycemia may increase, so blood sugar levels should be closely monitored. Fourth, dizziness or low blood pressure due to fluid volume loss may occur, so elderly individuals or those with low blood pressure should take extra caution, and if dehydration symptoms occur, the use of this medicine may be temporarily halted. Fifth, this medicine is not recommended for women who are pregnant or breastfeeding, and consultation with a doctor is essential if planning for pregnancy or if already pregnant. Sixth, this medicine has not been confirmed for safety and efficacy in children under the age of 18, and its use is not recommended. Finally, taking this medicine may involve risks during driving or operating machinery due to hypoglycemia, so caution is necessary. Before and during the use of this medicine, discuss thoroughly with your physician, and report any unusual symptoms to healthcare personnel immediately.

Side effects

  • urinary tract infection
  • vulvovaginitis
  • vulvitis
  • balanitis
  • genital infection
  • hypersensitivity
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 169 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • formation of oral ulcers
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • blood volume depletion
  • increased urination
  • urination difficulty
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • epigastric pain
  • enterocolitis
  • intestinal obstruction
  • gastritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech impairment
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial edema
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • abdominal pain
  • gastrointestinal disturbance
  • irritable bowel syndrome
  • burning mouth syndrome
  • colitis
  • abdominal discomfort
  • dysphagia
  • gastric ulcer
  • gum bleeding
  • tooth loss
  • hemorrhoids
  • lower abdominal pain
  • diarrhea
  • vomiting
  • gastritis
  • acute pyelonephritis
  • leukoplakia
  • rhinitis
  • soft tissue infection
  • pharyngitis
  • scrub typhus
  • periodontitis
  • tonsillitis
  • laryngitis
  • viral upper respiratory infection
  • tonsillitis
  • decreased appetite
  • hypercholesterolemia
  • inadequate control of diabetes
  • malnutrition
  • hyponatremia
  • headache
  • drowsiness
  • chest discomfort
  • weakness
  • nosebleed
  • oropharyngeal pain
  • voice disorder
  • allergic rhinitis
  • exertional dyspnea
  • wet cough
  • arthralgia
  • osteoporosis
  • arthropathy
  • musculoskeletal discomfort
  • myositis
  • myalgia
  • soft tissue mass
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • increased triglycerides in blood
  • increased urine albumin/creatinine ratio
  • positive urine leukocytes
  • decreased hemoglobin
  • increased blood potassium
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • male pattern baldness
  • hyperhidrosis
  • hair loss
  • dermatitis
  • anxiety
  • affective disorder
  • insomnia
  • depression
  • contusion
  • bone contusion
  • concussion
  • bone fracture
  • hand fracture
  • glaucoma
  • dry eyes
  • cataract
  • ocular discomfort
  • allergic conjunctivitis
  • polyuria
  • proteinuria
  • stress urinary incontinence
  • hematuria
  • hearing loss
  • erectile dysfunction
  • thyroid gland enlargement
  • anemia
  • lymphadenopathy
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • obesity
  • hypotension
  • flushing
  • otalgia
  • postural dizziness
  • dizziness
  • hypothyroidism
  • thyroid nodule
  • weight loss
  • osteoarthritis
  • limb pain
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help preserve the drug's effectiveness and safety for a long time.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.